Endocrinology

ODYSSEY DM-DYSLIPIDEMIA is 1 of 2 studies on alirocumab presented at ADA Scientific Sessions.

ODYSSEY DM-INSULIN is 1 of 2 studies on alirocumab presented at ADA Scientific Sessions.

Merck and Pfizer have announced that VERTIS MET and VERTIS SITA met primary endpoints.

Patients who switched to insulin glargine 300 Units/mL were 57% less likely to experience hypoglycemia at 6-months.

Teens with T1D improved their A1C levels by frequent 2-way texting.

Severely obese American Indian children had a 12-times higher risk of developing T2D as normal-weight youth.

Boys who are overweight as children but normalize as young adults have the same risk of type 2 diabetes as men who were never overweight.

More than 3,000 original research presentations will be offered in a robust 5-day program.

Babies are larger at birth and twice as likely to be obese at age 7

One of the fundamental facets of being a physician is continual learning. Shouldn’t we also pursue this in other areas, especially leadership?

Glioma is less common among diabetes patients.

Sugar Sponges could absorb and expel sugar in blood as needed.

MD Magazine® Peer Exchange® recently hosted an esteemed panel in which the topic of discussion was taking the personalized approach in type 2 diabetes management.

Recent research supports an aggressive bariatric BMI-based surgery selection.

Managing of type 1 diabetes mellitus (T1DM) is a full-time job.

Longer drug regimens increase the chance that patients will experience adverse drug effects or drug interactions.

Type 1 and 2 diabetes require patients to exercise vigilance and actively manage their conditions.

Experts caution duration of testosterone replacement therapy.

Maintaining glycemic control using insulin.

Approaches to orienting and training a nurse practitioner, keeping lines of communication open, and overcoming challenges are discussed.

Three studies examined the relationship between CVD risk and vitamin D status in children, adolescents, and women.

Expert speaks on management of patients with diabetes and chronic kidney disease.

Treatment options for end-stage renal disease should include peritoneal dialysis.

Jane McDaniel, MS, MLS (SCP) SC, Wake Forest School of Medicine explained that typically, the most common forms that are talked about are the thyroid panel, but most physicians will end up ordering a thyroid-stimulating hormone (TSH) to start with.

The FDA has required new warnings be added to drug labels.

A German study examined the intestinal microbiomes of 20 HF patients.

Warmer temperatures are affecting more pregnant women, study says.

Researcher calls it "some of the most exciting research in my career."

Whether you’re looking to make a change in employment, or are just curious, we’ve compiled a list of top hospital employers.

The Synthroid brand of levothyroxine improved thyroid-stimulating hormone (TSH) levels by a significantly greater margin compared with generic versions of the synthetic T4 (LT4) hormones for patients with hypothyroidism.